Robert Shoemaker
Chief Tech/Sci/R&D Officer chez ERASCA, INC.
Profil
Robert Shoemaker is currently working as the Senior Vice President-Research at Erasca, Inc. He previously worked as the Bioinformatics Director at Ignyta Operating, Inc. and as the Director-Bioinformatics Department at Ignyta, Inc. He also worked as a Scientist at Illumina, Inc. from 2011 to 2012.
Dr. Shoemaker completed his undergraduate, graduate, and doctorate degrees at the University of California San Diego.
Postes actifs de Robert Shoemaker
| Sociétés | Poste | Début |
|---|---|---|
| ERASCA, INC. | Chief Tech/Sci/R&D Officer | 18/01/2022 |
Anciens postes connus de Robert Shoemaker
| Sociétés | Poste | Fin |
|---|---|---|
| ILLUMINA, INC. | Corporate Officer/Principal | 01/01/2012 |
| IGNYTA INC | Corporate Officer/Principal | - |
Ignyta Operating, Inc.
 Ignyta Operating, Inc. Pharmaceuticals: MajorHealth Technology Ignyta Operating, Inc. develops molecular diagnostics for cancer and immunology. It is a biotechnology company developing personalized medicines for high unmet need cancer indications, based on cancer genome mining and sequencing. The firm's products include TrailblazeDx for RA, TrailblazeTx for RA, TrailblazeDx for SLE, TrailblazePx for SLE and TrailblazeTx for SLE. The company was founded in August 2011 by Jonathan E. Lim and Gary S. Firestein and is headquartered in San Diego, CA. | Corporate Officer/Principal | - |
Formation de Robert Shoemaker
| University of California San Diego | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ILLUMINA, INC. | Health Technology |
| ERASCA, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Ignyta Operating, Inc.
Ignyta Operating, Inc. Pharmaceuticals: MajorHealth Technology Ignyta Operating, Inc. develops molecular diagnostics for cancer and immunology. It is a biotechnology company developing personalized medicines for high unmet need cancer indications, based on cancer genome mining and sequencing. The firm's products include TrailblazeDx for RA, TrailblazeTx for RA, TrailblazeDx for SLE, TrailblazePx for SLE and TrailblazeTx for SLE. The company was founded in August 2011 by Jonathan E. Lim and Gary S. Firestein and is headquartered in San Diego, CA. | Health Technology |
Ignyta, Inc.
 Ignyta, Inc. BiotechnologyHealth Technology Ignyta, Inc. operates as a medicine biotechnology company. The firm engages in the discovering, acquiring, developing and commercializing targeted new drugs for cancer patients. The company was founded by Jonathan E. Lim on September 13, 2011 and is headquartered in South San Francisco, CA. | Health Technology |
